The Canada Cannabis Spot Index was assessed at C$5.12 per gram this week, down 0.7% from last week’s C$5.15 per gram. This week’s price equates to US$1,844 per pound at the current exchange rate.
Each week, Business of Cannabis delivers a series of insights from our partners at Cannabis Benchmarks®.
This week, Cannabis Benchmark provides an update on their cannabis retail sales estimate for the remainder of this year and next year. Over the past three years, the Canadian cannabis industry saw sales grow each month at a similar pace as the number of new retail outlets opening across the country.
At the end of September, Canada crossed the milestone of 2,500 stores. Cannabis Benchmarks recently forecast that monthly retail sales across Canada reached C$333 as of September 2021.
For the remainder of 2021 and through 2022, Cannabis Benchmarks forecast that sales growth will continue as provinces such as Ontario, British Columbia and Quebec make legal cannabis more accessible by adding more retail stores.
In 2022, however, Cannabis Benchmarks expects growth to moderate as certain highly populated pockets of Canada become saturated with cannabis stores, leading to lower sales per store and a continued downtrend in retail prices across the provinces.
Additionally, the conversion rate of buyers from the illicit market has slowed as some buyers remain committed to their informal sales channels.
Overall, Cannabis Benchmarks sees sales climbing to C$383M by December 2022, a 12% increase to July 2020, which is the last monthly figure published by Statistics Canada.
On a cumulative basis, 2022 sales are expected to grow to C$4.34B which is a 13% increase over our estimated total for 2021.
A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.
Home / Cumulative annual Canada legal cannabis sales
Cumulative annual Canada legal cannabis sales
The Canada Cannabis Spot Index was assessed at C$5.12 per gram this week, down 0.7% from last week’s C$5.15 per gram. This week’s price equates to US$1,844 per pound at the current exchange rate.
Each week, Business of Cannabis delivers a series of insights from our partners at Cannabis Benchmarks®.
This week, Cannabis Benchmark provides an update on their cannabis retail sales estimate for the remainder of this year and next year. Over the past three years, the Canadian cannabis industry saw sales grow each month at a similar pace as the number of new retail outlets opening across the country.
At the end of September, Canada crossed the milestone of 2,500 stores. Cannabis Benchmarks recently forecast that monthly retail sales across Canada reached C$333 as of September 2021.
For the remainder of 2021 and through 2022, Cannabis Benchmarks forecast that sales growth will continue as provinces such as Ontario, British Columbia and Quebec make legal cannabis more accessible by adding more retail stores.
In 2022, however, Cannabis Benchmarks expects growth to moderate as certain highly populated pockets of Canada become saturated with cannabis stores, leading to lower sales per store and a continued downtrend in retail prices across the provinces.
Additionally, the conversion rate of buyers from the illicit market has slowed as some buyers remain committed to their informal sales channels.
Overall, Cannabis Benchmarks sees sales climbing to C$383M by December 2022, a 12% increase to July 2020, which is the last monthly figure published by Statistics Canada.
On a cumulative basis, 2022 sales are expected to grow to C$4.34B which is a 13% increase over our estimated total for 2021.
Source: Canada Cannabis Spot Index, Cannabis Benchmarks
See previous weekly updates from Cannabis Benchmarks:
BofC
Other featured articles
Nine of the Ten Top CBPM Prescribers Are Pharmacists, FOI Data Shows
By
Cannabis Inherits Its Future: What the Eye Can’t See
By
UK Medical Cannabis Market Growing ‘Faster Than Anyone Expected’
By
How Countries Legalise Cannabis Matters More Than Whether They Do, Lancet Review Finds
By
European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
By
Other featured Data & Analysis articles
Nine of the Ten Top CBPM Prescribers Are Pharmacists, FOI Data Shows
By
Cannabis Inherits Its Future: What the Eye Can’t See
By
UK Medical Cannabis Market Growing ‘Faster Than Anyone Expected’
By
How Countries Legalise Cannabis Matters More Than Whether They Do, Lancet Review Finds
By
European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
By
Share Article
The Briefing / Newsletter
Insights
you don't want
to miss.
A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.
Related news
Nine of the Ten Top CBPM Prescribers Are Pharmacists, FOI Data Shows
By
Cannabis Inherits Its Future: What the Eye Can’t See
By
UK Medical Cannabis Market Growing ‘Faster Than Anyone Expected’
By
How Countries Legalise Cannabis Matters More Than Whether They Do, Lancet Review Finds
By
European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
By
Do 10 Doctors Really Prescribe Half of England’s Medical Cannabis?
By
Public Data is No Longer Enough to Understand the German Medical Cannabis Market
By
UK Medical Cannabis Imports Hit 30 Tonnes as Canadian Producers Bypass European Processors
By
International News Round-Up: Australian medical cannabis sales plummet, smokable ban looms in Israel and more…
By